PRECLINICAL STUDIES IN HEPATIC & RENAL DISEASES
Addressing potential opportunities for hepatic and renal disease treatments.
SHAPING POSSIBILITIES IN HEPATIC AND RENAL DISEASE TREATMENTS AND CURES
If there’s one thing our pharmacology experts at PharmaLegacy are good at, it’s leveraging their exhaustive knowledge to facilitate the journey of your pipeline all the way to the clinical setting. Hepatic diseases and renal diseases require no introduction. Whether you are working on new liver cirrhosis treatments, or novel ways to alleviate the signs and symptoms of nephrotic syndrome, PharmaLegacy’s expert staff, who have kept more than half of the top 20 pharmaceutical companies satisfied for years in a row, is at your service.
Our team of experts, averaging 15 years of experience in the pharmaceutical field, is sure to meet your expectations, and exceed them. Choose a CRO that goes the extra mile. Work with PharmaLegacy.
- Scientific staff with an average of over 15 years of experience in pharmacology
- Completed over 400 FDA / CFDA IND filings
- 150,000 square feet of facility space
- Rigorous adherence to international GLP and QA best practices